Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemiaJorge J. Yunis, Richard D. Brunning, Robert E. Rydell et al.|British Journal of Haematology|1988Cited by 233